Home LiteratureArticle Details
PMID: 9727055 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.

The Journal of clinical investigation ·Vol. 102 ·No. 5 ·1998-09-01 ·Pages 874-80

Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M, Wilson JM

Abstract

Previous studies have implicated the novel peptide antibiotic human beta-defensin 1 (hBD-1) in the pathogenesis of cystic fibrosis. We describe in this report the isolation and characterization of the second member of this defensin family, human beta-defensin 2 (hBD-2). A cDNA for hBD-2 was identified by homology to hBD-1. hBD-2 is expressed diffusely throughout epithelia of many organs, including the lung, where it is found in the surface epithelia and serous cells of the submucosal glands. A specific antibody made of recombinant peptide detected hBD-2 in airway surface fluid of human lung. The fully processed peptide has broad antibacterial activity against many organisms, which is salt sensitive and synergistic with lysozyme and lactoferrin. These data suggest the existence of a family of beta-defensin molecules on mucosal surfaces that in the aggregate contributes to normal host defense.

MeSH Terms
Amino Acid Sequence Anti-Bacterial Agents/chemistry,pharmacology Anti-Infective Agents/chemistry Blood Proteins/chemistry,urine Bronchoalveolar Lavage Cloning, Molecular Cystic Fibrosis/physiopathology Defensins Humans In Situ Hybridization, Fluorescence Lactoferrin/pharmacology Lung/chemistry Molecular Sequence Data Muramidase/pharmacology Peptide Fragments/chemistry Proteins/chemistry RNA, Messenger/metabolism Recombinant Proteins/chemistry,pharmacology Salts/pharmacology Sequence Analysis, DNA beta-Defensins
Chemicals
Anti-Bacterial Agents Anti-Infective Agents Blood Proteins DEFB1 protein, human DEFB4A protein, human Defensins Peptide Fragments Proteins RNA, Messenger Recombinant Proteins Salts beta-Defensins Muramidase Lactoferrin
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Bals R
Institute for Human Gene Therapy, Department of Medicine and Molecular and Cellular Engineering, The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
Wang X
Wu Z
Freeman T
Bafna V
Zasloff M
Wilson J M
References (19)
19 references, click to expand
  1. Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis.
    J Lab Clin Med. 1990 Feb;115(2):148-58 PMID: 2299262
  2. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.
    J Clin Invest. 1998 Apr 15;101(8):1633-42 PMID: 9541493
  3. Increased bronchial chloride concentration in cystic fibrosis.
    Scand J Clin Lab Invest. 1989 Apr;49(2):121-4 PMID: 2520363
  4. Airway epithelial cells are the site of expression of a mammalian antimicrobial peptide gene.
    Proc Natl Acad Sci U S A. 1993 May 15;90(10):4596-600 PMID: 8506305
  5. Elemental composition of human airway surface fluid in healthy and diseased airways.
    Am Rev Respir Dis. 1993 Dec;148(6 Pt 1):1633-7 PMID: 8256912
  6. Structure and diversity of the murine cryptdin gene family.
    Genomics. 1994 Feb;19(3):448-53 PMID: 8188287
  7. Defensins.
    Curr Opin Immunol. 1994 Aug;6(4):584-9 PMID: 7946046
  8. Epithelial antibiotics induced at sites of inflammation.
    Science. 1995 Mar 17;267(5204):1645-8 PMID: 7886453
  9. Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis.
    BMJ. 1995 Jun 17;310(6994):1571-2 PMID: 7787647
  10. hBD-1: a novel beta-defensin from human plasma.
    FEBS Lett. 1995 Jul 17;368(2):331-5 PMID: 7628632
  11. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.
    Cell. 1996 Apr 19;85(2):229-36 PMID: 8612275
  12. Coordinate induction of two antibiotic genes in tracheal epithelial cells exposed to the inflammatory mediators lipopolysaccharide and tumor necrosis factor alpha.
    Infect Immun. 1996 May;64(5):1565-8 PMID: 8613361
  13. Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis.
    Pediatr Pulmonol. 1996 May;21(5):267-75 PMID: 8726151
  14. Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation.
    Clin Infect Dis. 1996 Sep;23(3):532-7 PMID: 8879776
  15. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis.
    Cell. 1997 Feb 21;88(4):553-60 PMID: 9038346
  16. A peptide antibiotic from human skin.
    Nature. 1997 Jun 26;387(6636):861 PMID: 9202117
  17. Efficient non-PCR-mediated overlap extension of PCR fragments by exonuclease "end polishing".
    Biotechniques. 1997 Jul;23(1):48, 50, 52 PMID: 9232225
  18. Ion composition of airway surface liquid of patients with cystic fibrosis as compared with normal and disease-control subjects.
    J Clin Invest. 1997 Nov 15;100(10):2588-95 PMID: 9366574
  19. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA.
    Proc Natl Acad Sci U S A. 1991 May 1;88(9):3952-6 PMID: 2023943
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1998-09-01
Pages
874-80
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC508952
Subset
IM
Grants
NIDDK NIH HHS · P30 DK47757-04 · United States
NHLBI NIH HHS · R01 HL49040-06 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]